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transformed into a glassy-state, has emerged as an alternative to the presently applied means of cryopreservation. However, conventional vitrifi cation requires high concentrations of CPAs to achieve successful vitrifi cation. CPA acts as antifreeze to the cytosol and as a stabilizer for the plasma membrane; but, it is toxic to cells when used in high concentrations. [ 9, 10 ] Although vitrifi cation has shown advantages over traditional cryopreservation techniques, it has not been incorporated into transfusion medicine mainly due to an inability to achieve vitrifi cation with bulk volumes and throughput challenges. Therefore, innovative technologies for vitrifi cation could improve RBC preservation success, which is urgently needed to advance the clinical practice of transfusion medicine and expand RBC preservation options for patients. Moreover, the use of bio-inspired materials in this context can offer additional benefi ts. [ 11 ] Recent advances in manipulating cells and droplets have been made, particularly at the interface between bioengineering, biomaterials, and medicine. [ 12 ] In one important instance, a new technology-enabled capability of printing viable
The unique morphology and mechanics of red blood cells (RBCs) are critical in infl uencing their function. [ 1 ] Recent studies have revealed detrimental alterations in RBC morphological, mechanical, and functional properties (collectively termed as "storage injury") during RBC hypothermic liquid preservation. [ 2 ] Such adverse storage changes correlate with increased mortality and morbidity rates in medically compromised patients when RBCs are stored for more than 14 days. [ 3 ] Cryopreservation has emerged as an alternative approach that extends the RBC preservation period for years by overcoming the adverse changes that occur in liquid preservation. Although RBC cryopreservation is clinically employed, adverse morphological, [ 4 ] mechanical, [ 5 ] and functional [ 6 ] changes still present challenges. Current RBC cryopreservation techniques utilize glycerol in slow-freezing [ 7 ] and rapid-freezing techniques. [ 53 , 8 ] Several causative factors have been shown to be involved in cryo-injury; however, cryoprotective agent (CPA) used, as well as cooling and rewarming approaches, are detrimental. [ 9 ] In contrast, vitrifi cation, in which cells are
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and functional cells has been reported. [ 51 , 13 ] In the present study, we report the preservation of human RBC morphology, mechanics, and function following vitrifi cation using a novel cryo-ink integrated with a cryo-printer, a droplet generation tool that can transform a bulk volume of human blood into nanoliter droplets on a cryo-paper. The results reveal that the recovered RBCs after ectoine-assisted vitrifi cation, maintained their characteristic features, such as morphology, submembranous spectrin-actin network, and mechanical properties. In addition, the essential functions of recovered RBCs such as phosphorylation of band-3 protein, expression of complement receptor 1, and maintenance of intracellular nitric oxide and the reactive oxygen species are effectively preserved.
To transform a bulk sample of RBCs into nanoliter volume droplets in a bio-inspired cryo-ink, we developed a cryo-printing methodology ( Figure 1 ). In this method, the cryo-ink acts as a cryoprotective agent to help the cells overcome the shock during the cooling and rewarming processes of cryopreservation. The cryo-printer contains an ejector in which the RBC-CPA mixture and the nitrogen gas are simultaneously expelled leading to the formation of nanoliter size droplets at the ejector outlet (Figure 1 a) . The cryo-printer in our experiments produces considerably small volumes of droplets (0.14 ± 0.096 nL, Figure S1 in the Supporting Information (SI)), with the aim being to minimize the adverse effects on RBCs by eliminating the requirements of high CPA concentrations to achieve vitrification. Vitrifi cation using nanoliter droplets requires low concentrations of CPA (4.5%), while conventional methods, which utilize bulk volumes (450-500 mL), require high concentrations of CPAs (20-40%). Such high concentrations of CPAs loaded into bulk samples for conventional methods have been reported to cause adverse effects on RBCs. [ 14 ] In addition, small volumes of droplets provide ultra-high cooling and rewarming rates that enable preservation of cells without ice crystal formation.
Prior to cooling, blood samples were loaded with a cryo-protective ink at 1:1 dilution. A possible osmotic shock emerging from the exposure to the cryo-ink that could lead to RBC loss, was evaluated via hemolysis and revealed to be insignifi cant ( Figure S2 in the SI). This cryo-ink contains ectoine (9% v/v), trehalose (25 µg mL -1 ), and polyethylene glycol (PEG, 1% v/v) (Figure 1 b) . The optimal concentration of ectoine in the cryoink was determined as a result of a set of hemolysis analysis ( Figure S3 in the SI). Ectoine is a naturally occurring solute present in the extremophilic bacteria which are capable of adapting to extreme thermal and osmotic stress conditions. [ 15 ] This capability is associated with the preferential exclusion of ectoine at the interface of a lipid monolayer of the cell membrane. The exclusion leads to expansion of the membrane, promoting the penetration of water molecules. [ 16, 17 ] The increased number of water molecules in the vicinity of the lipids improves the membrane fl uidity, which is crucial to withstand osmotic shock and to assist in the cell repair mechanisms. [ 16 ] Ectoine-containing CPA solutions have previously been employed for mesenchymal stem-cell preservation with conventional slow-freezing protocols. [ 11 ] The cryo-ink solution used in this study contains in addition to ectoine, trehalose, and PEG, which have complementary enhancing effects. [ 18, 19 ] For example, PEG suppresses the freezing point of the solution. [ 19 ] We utilized vitrifi cation (below -150 °C) as a cooling method instead of conventional freezing (-80 °C or above) to minimize cryo-injury. [ 52 ] Vitrifi cation occurs when the CPA-loaded RBCs are super-cooled down to the glass-transition temperature and adopt a glass-like amorphous morphology. [ 10 ] This is different than conventional freezing where the cell injury, caused by the formation of ice crystals, is of concern. [ 10, 20 ] The printing of the nanoliter droplets on a cryo-paper (nonporous polyethylene collection fi lm with 8.5 cm in diameter) and subsequent submersion into liquid nitrogen (-196 °C) results in immediate vitrifi cation of the RBCs (Figure 1 c) . One of the major challenges in conventional vitrifi cation is ice crystallization, which occurs during rapid rewarming. [ 10 ] Ice crystallization occurs as a result of the latent heat of fusion, causing hemolysis of the cells. [ 10 ] To avoid such crystallization, vitrifi ed blood sample was ultra-rapidly rewarmed by immersing the printed nanoliter droplets on cryo-paper in warm media (≥37 °C) (Figure 1 b) . Furthermore, utilizing bio-inspired CPAs; such as ectoine and trehalose, in low concentrations eliminates extensive washing steps that are required for other protocols, such as glycerol-based techniques. The washing step is minimal in this method and is achieved by re-suspending the RBCs in PBS.
The The system consists of nitrogen gas fl ow and a droplet deposition system controlled by a syringe pump. The droplets are generated from the co-fl ow stream of cryoprotective agent (CPA)-loaded red blood cell (RBC) mixture as the nitrogen gas fl ows through a droplet ejector, which transforms the bulk of the sample into nanoliter droplets. The CPA consists of a cocktail solution of ectoine, trehalose, and polyethylene glycol (PEG). The droplets were ejected on a cryo-paper (polyethylene collection fi lm). b) Schematic magnifi ed view of a single droplet on the cryo-paper including RBCs, ectoine, trehalose, and PEG. c) Schematic view of the vitrifi ed droplet in (b) . Vitrifi cation is achieved by submersing the cryo-paper into liquid nitrogen. The vitrifi ed droplet transforms to (b) after rapid thawing of the cells on a cryo-paper in phosphate-buffered saline at 37 °C.
The biconcave shape increases the oxygen-delivering capacity of RBCs provided by the high surface area in close proximity to the vessel walls. [ 21 ] Additionally, RBCs owe their extreme fl exibility to their biconcave shape, [ 22 ] which allows them to travel through the microvasculature. If RBCs are challenged by mild environmental fl uxes such as slight osmotic changes, [ 23 ] reversible morphological alterations may occur. One example is the transformation to echinocytes ( Figure S4 in the SI), where the plasma membrane exhibits small projections. [ 24 ] Irreversible shape changes of RBCs are indicated by the formation of spherocytes, the completely round forms of RBCs. [ 25 ] To investigate the changes in morphology of recovered RBCs subsequent to ectoine-based vitrifi cation (EV), a series of scanning electron micrographs (SEMs) were obtained (Figure 2 a-d and S5a-r in the SI). The cells visualized by SEM were categorized under three different groups exhibiting: i) no change (biconcave discocytes), ii) reversible change (e.g., echinocytes and stomatocytes), and, iii) irreversible change (spherocytes). [ 26 ] For each group, the number of recovered cells was considered to be the total count of the biconcave RBCs LGV and LGSF go through signifi cant irreversible shape changes (mainly spherocytes): 83% and 88% of the entire population of cells, respectively ( Figure 2 g and h) . This is in agreement with the previous observations of the transformation of biconcave human RBCs [ 4 ] and mesenchymal stem cells [ 11 ] to spherocytes upon glycerol-based cryopreservation. 
altered RBC morphology after transfusion of stored blood have reported a reduced capacity of RBCs to oxygenate the tissues, [ 27 ] increasing the risk for peripheral ischemia and deep venous thrombosis. [ 28 ] Spectrin and actin proteins construct the major backbone of the RBC skeleton, which is altered when these proteins are damaged. [ 22 ] To investigate the effect of EV on the RBC cytoskeleton, we performed immunocytochemistry to evaluate the distribution of spectrin (α-and β-chains) and actin fi laments of recovered cells (Figure 2 q-t) . The pattern distribution across the recovered RBCs after EV was comparable to the control RBCs (Figure 2 q and r) . The RBCs recovered after LGV and LGSF showed different protein distribution patterns where the central spectrin-actin region was distorted (Figure 2 
s) or disintegrated (Figure 2 t and S6 in the SI).
To test the mechanical properties of recovered RBCs, we evaluated the membrane stiffness, cell deformability, and membrane fl ickering. Cell stiffness was evaluated by measuring the elastic moduli of the cells using AFM. [ 54 ] The stiffer the cell, the higher its elastic modulus. [ 29 ] Recovered RBCs after EV displayed comparable stiffness (461 ± 38 Pa) to control RBCs (358 ± 38 Pa; Figure 3 a) . The recovered cells were incubated in autologous plasma for 3 h to evaluate the membrane stiffness ex vivo. On the other hand, RBCs recovered after LGSF displayed greater ( p < 0.05) stiffness (879 ± 47 Pa, Figure 3 a) compared to the control. Another characteristic of RBCs is their signifi cant deformability which enables them to pass through capillary veins and exchange oxygen and carbon dioxide with cells in tissues. [ 30 ] We have measured the deformability by forcing the recovered RBCs to pass through 4.5 µm wide and 2 µm high microchannels (Figure 3 b) and by evaluating the duration of their travel along the channels (Figure 3 c) . This evaluation is based on the fi ndings from previous reports [ 31 ] which indicate a relatively more fl exible cell would be able to pass through the channel in a shorter time, compared with a less-deformable cell.
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The RBCs recovered from EV passed through the microfl uidic channels 1.3 s faster on average compared with control RBCs (Figure 3 c) . The difference is statistically signifi cant ( p < 0.05) and indicates higher deformability of the recovered cells after EV. The measurements were performed on the fresh blood at room temperature (20-24 °C). The corresponding measurements on recovered RBCs from EV were also performed at room temperature but after the cells experienced signifi cant temperature changes during cooling and rewarming (-198 to 37 °C). The increase in the deformability of RBCs measured in a similar microfl uidic system was linked to temperature changes. [ 32 ] An increase in RBC deformability was previously investigated but was not linked to negative effects [ 5, 33 ] whereas a decrease in deformability was associated with blood related diseases [ 30, 34 ] and low quality of stored blood. [ 2 ] The analysis on the deformability of the RBCs could not be performed for the LGV and LGSF due to blockage of microchannels by the RBCs in these two groups. Earlier reports have associated the reduced deformability in stored RBCs with irreversible shape changes, such as those observed for spherocytes. [ 35 ] The membrane fl ickering of recovered cells, also known as fl uctuations or oscillations, was evaluated as a functional response of RBCs. [ 36 ] The fl ickering was quantifi ed by recording changes in light scattering at the surface of a RBC using timelapse, positive-low phase-contrast microscopy over a period of 30 s at frequency of 33 frames s -1 (Figure 3 d-l) . The intensity of scattered light was used to calculate the coeffi cient of variance at each point. These fl uctuations show that the recovered RBCs after EV maintained their fl ickering amplitude at levels comparable with fresh RBCs (Figure 3 d) . However, the amplitude of membrane fl ickering in the recovered cells after LGV and LGSF differs signifi cantly ( p < 0.05) from both control and recovered RBCs after EV (Figure 3 d) . Loss of fl ickering amplitude has been observed in RBCs during multiple diseases, such as systemic lupus erythematosus and malaria infection. [ 30, 37 ] The pseudo-color images in Figure 3 e-h represent a map of the coeffi cient of variance on the RBCs measured as a sum of each pixel covering the cell surface during 30 s. Figure 3 i-l shows the amplitude of intensity of a representative pixel corresponding to the pseudo-color images in Figure 3 e-h.
To evaluate the functional properties of EV recovered RBCs, we measured band-3 phosphorylation ( Figure 4 a) , CD35 expression (Figure 4 b) , intracellular nitric oxide (NO) (Figure 4 c) , and intracellular reactive oxygen species (ROS) (Figure 4 d) . The measurements were performed by fl ow cytometry after incubation in 25% serum from a known universal donor. Band-3 is an integral protein that regulates RBC membrane organization and function. [ 38 ] Alteration of band-3 phosphorylation levels has been associated with increased rigidity of RBCs, therefore, decreasing their perfusion to host organs and their lifespan in the circulation. [ 39 ] Although there was a slight decrease of band-3 phosphorylation level in recovered RBCs after EV (geometric mean: 25) compared to control RBCs (geometric mean: 29.7), the decrease was not signifi cant (Figure 4 a) . CD35 (also known as complement receptor 1, CR1), is a unique human RBC regulatory protein, [ 40 ] critical in the immune-clearance process and thus for the maintenance of a non-infl ammatory intravascular environment. [ 41 ] Injury associated with RBC storage changes the tendency of CD35 to cluster on the cell membrane, which ultimately reduces the ability of the cell to capture and transport the infl ammatory particles, thereby maintaining the non-infl ammatory status of the circulatory system. [ 41 ] The recovered RBCs after EV showed a comparable CD35 expression level to the control RBCs that were collected from the same donor with geometric means of 7.5 and 8.0, respectively (Figure 4 b) .
The intracellular NO and ROS levels as regulators for blood fl ow and RBC homeostasis were also evaluated. [ 42 ] NO is a crucial short-lived signaling molecule regulating local vasodilation. [ 43 ] Loss of NO has been observed after prolonged storage of RBCs and it has been linked to biochemical (e.g., depletion of adenosine triphosphate and 2,3-diphosphoglycerate) or hemolysis-related changes including morphology and deformability changes. [ 44 ] Formation of ROS during the preservation process has been also shown to accelerate RBC storage injury and signifi cantly reduce post-transfusion RBC viability. [ 45 ] ROS are highly reactive molecules that target a wide range of cell components, including lipids, nucleic acids, and proteins (i.e., spectrin in RBCs), which undergo irreversible ROS-mediated changes resulting in signifi cant decreases in RBC deformability. [ 46 ] Our results demonstrated that the cells recovered after EV maintained the intracellular NO (geometric mean: 9.6) and ROS levels (geometric mean: 6.7) compared to control RBCs (geometric means: 8.8 and 7.2, respectively) ( Figure 4 b-d) . In addition, fl ow cytometry results clearly reveal the preservation of recovered RBC morphology after EV, fully supporting our SEM and AFM results shown in Figure 1 (see Figure S7 in the SI).
In this study, we report the preservation of human red blood cell (RBC) morphology, mechanics, and function following vitrifi cation in nanoliter volumes using an innovative cryo-ink integrated with a bio-printing approach. The use of nano-liter droplet vitrifi cation for the purpose of cryopreservation of RBCs has not been well studied or applied, [ 10 ] although it could potentially provide a powerful means to cryopreserve RBCs for blood banking. One challenge is the transformation of the concept into a high-throughput system where large volumes of blood are rapidly vitrifi ed. We have previously demonstrated the scalability of droplet system by developing arrays consisting of multiple ejectors for droplet generation, which could potentially enables automation and high-throughput processing. [ 47 ] We envision that a series of such arrays would provide rapid printing of droplets for bulk volumes of blood samples before vitrifi cation. Furthermore, the presented method has the potential to minimize cell contamination by using sterilized liquid nitrogen (LN 2 ). It has been shown that LN 2 can be sterilized by utilizing ultraviolet radiation, [ 48 ] or sterile PTFE cartridge fi lters, [ 49 ] minimizing such contamination risks. [ 50 ] Therefore, the presented method has the potential for minimizing such contamination risks and allowing the sterilization of potential automated high-throughput applications by bringing multiple ejectors together. Additionally, we observed a mild increase in the hemolysis when using the polyethylene collection fi lm ( Figure S8 in the SI). The hemolysis at this collection step could be eliminated with the use of materials that would enable less mechanical stress upon collection, for example a soft and biocompatible fi brin fi lm. The RBCs cryoprinting step was also evaluated and compared with manually pipetting of CPA-loaded RBCs (control). None of the printed groups (EV and LGV) show signifi cant increase in hemolysis COMMUNICATION above the acceptable level, thereby validating the cryoprintingbased system ( Figure S8 in the SI) .
Here, we demonstrated the cryo-printing of the ectoineloaded RBCs encapsulated in nanoliter droplets. The printed RBCs on cryo-paper were vitrifi ed in extremely low temperatures. After rewarming the maintenance of RBC morphology, mechanics, and function were evaluated. Ectoine-assisted cryoprinting has the potential to improve the effi ciency of blood banking and further create new approaches to biopreserve various cell types, including stem cells, natural killer cells, and gametes.
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